[
    [
        {
            "time": "2023-10-05",
            "original_text": "Why AbbVie (ABBV) is a Great Dividend Stock Right Now",
            "features": {
                "keywords": [
                    "AbbVie",
                    "dividend",
                    "great stock"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Why AbbVie (ABBV) is a Great Dividend Stock Right Now",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "10 Best Dividend Stocks to Buy According to Billionaire Richard Chilton",
            "features": {
                "keywords": [
                    "best dividend stocks",
                    "Richard Chilton",
                    "buy"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "multiple sectors"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "10 Best Dividend Stocks to Buy According to Billionaire Richard Chilton",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO",
            "features": {
                "keywords": [
                    "FDA",
                    "approval",
                    "Alzheimer’s drug",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]